本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

德纳维制药

10.58
-0.3200-2.94%
盘后10.580.00000.00%19:36 EDT
成交量:384.09万
成交额:4,068.60万
市值:12.70亿
市盈率:-22.56
高:10.88
开:10.72
低:10.56
收:10.90
数据加载中...
2023/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/03

重要事件披露

Form 8-K - Current report
2023/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/06

重要事件披露

Form 8-K - Current report
2023/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/27

重要事件披露

Form 8-K - Current report
2023/05/20

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/04

关联方拟减持公告

144 - Report of proposed sale of securities
2023/05/02

重要事件披露

8-K - Current report
2023/05/02

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/02/23

重要事件披露

8-K - Current report
2023/02/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/01

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals